LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
To help detect and evaluate hemolytic anemia
When you have signs of anemia such as weakness, paleness, or jaundice that a healthcare practitioner suspects may be due to red blood cell destruction (hemolytic anemia)
A blood sample drawn from a vein
Haptoglobin is a protein produced by the liver that the body uses to clear free hemoglobin (found outside of red blood cells) from circulation. This test measures the amount of haptoglobin in the blood.
Hemoglobin is the iron-containing protein complex that transports oxygen throughout the body. It is normally found within red blood cells (RBCs) and very little is found free circulating in the blood. Haptoglobin binds to free hemoglobin in the blood. This forms a haptoglobin-hemoglobin complex that is rapidly cleared out of circulation by the liver so that it can be broken down and the iron recycled. Formation of the haptoglobin-hemoglobin complex also prevents hemoglobin from being filtered by the kidneys and passed into the urine, which can be toxic to the kidneys.
However, when an increased number of RBCs are damaged and/or break apart (hemolysis), they release their hemoglobin into the blood, increasing the amount of free hemoglobin in circulation. When large numbers of RBCs are destroyed, haptoglobin levels in the blood will temporarily decrease as the haptoglobin is used up faster than the liver can produce it. A decrease in the amount of haptoglobin may be a sign that you have a condition that is causing red blood cells to be destroyed or to break apart. When the binding capacity of haptoglobin is exceeded, the free hemoglobin level in circulation goes up and may cause tissue damage and/or organ dysfunction due to oxidative stress of free hemoglobin.
Increased RBC destruction may be due to inherited or acquired conditions. Some examples include transfusion reactions, certain drugs, and mechanical breakage, such as may be seen with some prosthetic heart valves. The destruction may be mild or severe, occurring suddenly (acute) or developing and lasting over a long period of time (chronic), and it can lead to hemolytic anemia. People with hemolytic anemia may experience symptoms such as fatigue, weakness, and shortness of breath and their skin may be pale or jaundiced.
Liver disease may also result in decreased haptoglobin levels as liver damage may inhibit both the production of haptoglobin and the clearing of the haptoglobin-free hemoglobin complexes.
Haptoglobin testing is used primarily to help detect and evaluate hemolytic anemia and to distinguish it from anemia due to other causes. Testing is used to help determine whether red blood cells (RBCs) are breaking apart or being destroyed prematurely. It may be used in conjunction with other laboratory tests such as a complete blood count (CBC, including RBC count, hemoglobin, hematocrit), reticulocyte count, lactate dehydrogenase, bilirubin, direct antiglobulin test, and blood smear.
Though the haptoglobin test is a sensitive test for hemolytic anemia, it cannot be used to diagnose the cause of the condition. Other laboratory tests may be needed to help determine the cause, such as tests for autoantibodies to detect autoimmune causes, sickle cell tests, G6PD, or a hemoglobin evaluation.
If you have had a blood transfusion, a haptoglobin test may be ordered along with a direct antiglobulin test to help determine if you have had a transfusion reaction. (For more details, see the article on Transfusion Medicine.)
If your haptoglobin level is low, then testing may be repeated at a later time to monitor your condition, evaluate changes in concentration, and help determine whether the increased destruction of RBCs persists.
The haptoglobin test is ordered when you have symptoms and signs associated with hemolytic anemia. Some examples include:
Testing may also be done when other laboratory test results are consistent with hemolytic anemia. These may show increased bilirubin, hemoglobin in the urine (hemoglobinuria), decreased RBC count, and increased reticulocyte count and lactate dehydrogenase levels.
Results are interpreted carefully and in conjunction with results of other tests, such as a reticulocyte count, red blood cell (RBC) count, hemoglobin (Hb), hematocrit (Hct), or complete blood count (CBC).
When your haptoglobin level is significantly decreased, along with an increased reticulocyte count and a decreased RBC count, hemoglobin, and hematocrit, then it is likely that you have some degree of hemolytic anemia with red blood cells destroyed in the circulation (intravascular hemolysis).
If your haptoglobin level is normal or borderline normal and your reticulocyte count is increased, then RBC destruction is likely occurring in organs such as the spleen and liver (extravascular hemolysis). Because the free hemoglobin is not released into the blood, the haptoglobin is not used up and remains at a normal level. However, in severe extravascular hemolysis, haptoglobin level can be low because excess hemolysis can release some free hemoglobin into circulation.
If your haptoglobin level is normal and the reticulocyte count is not increased, then it is likely that your anemia is not due to RBC breakdown but due to some other cause.
The following table summarizes some results that may be seen:
|Haptoglobin||Reticulocyte count||RBC count, Hemoglobin, Hematocrit||Possible interpretation|
|Significantly decreased||Increased||Decreased||RBCs are being destroyed within blood vessels (intravascular hemolysis)|
|Normal or slightly decreased||Increased||Decreased||RBCs destruction likely within organs such as the spleen and liver (extravascular hemolysis)|
|Normal||Not increased||Decreased||Anemia due to a cause other than RBC destruction (e.g., decrease in RBC production in the bone marrow)|
If haptoglobin is decreased without any signs of hemolytic anemia, then it is possible that the liver is not producing adequate amounts of haptoglobin. This may be seen with liver disease, although haptoglobin is not typically used to diagnose or monitor liver disease.
Congenital haptoglobin deficiency (called "anhaptoglobinemia" that is unrelated to hemolysis or liver disease) is also seen in the general population, affecting about 0.1% of Caucasians and 4% of African Americans (up to 30% in Africans of certain West African origin). Your healthcare provider may order additional tests (e.g., hemopexin test) to help determine if low haptoglobin is congenital or is related to RBC hemolysis.
A low level of haptoglobin is normal for newborns and infants less than 6 months old.
Haptoglobin is considered an "acute-phase" protein. This means that it will be elevated in many inflammatory diseases, such as ulcerative colitis, acute rheumatic disease, heart attack, and severe infection. If you have one of these conditions, it can complicate the interpretation of the haptoglobin results. Haptoglobin testing is not generally used to help diagnose or monitor these conditions.
Haptoglobin levels may be affected by massive blood loss and by conditions associated with kidney dysfunction as well as liver disease.
Drugs that can increase haptoglobin levels include androgens and corticosteroids. Drugs that can decrease haptoglobin concentrations include isoniazid, quinidine, streptomycin, and birth control pills.
It depends on the cause of the low level. If it is due to acute hemolysis, such as may be seen with a transfusion reaction, then it will return to normal once the reaction resolves. If it is due to chronic hemolysis, then the level should return to normal if and when the underlying condition can be resolved. If the underlying condition cannot be resolved or if the decreased level of haptoglobin is due to decreased production due to liver disease, then the level may continue to be lower than normal.
In most cases, no. This test is typically either performed in a hospital laboratory or sent to a reference laboratory.
The haptoglobin test may be also ordered inside the laboratory to differentiate between a hemolyzed specimen due to RBCs' destruction inside the body from a hemolyzed specimen due RBCs' destruction after a blood draw. However, few studies have been found that support this use.
Sources Used in Current Review
2020 Review completed by Hoda Hagrass, MD, Ph.D., Medical Director of clinical chemistry and immunology laboratories, UAMS.
Haptoglobin (HP) Test. MedlinePlus. Available online at https://medlineplus.gov/lab-tests/haptoglobin-hp-test/ Accessed on 8/25/2020.
Andersen C., Torvund-Jensen M., Nielsen M., et al. Structure of the haptoglobin–haemoglobin complex. Nature 489, 456–459 (2012). Available online at https://doi.org/10.1038/nature11369. Accessed August 2020.
Shih AW, McFarlane A, Verhovsek M. Haptoglobin testing in hemolysis: measurement and interpretation. Am J Hematol. 2014;89(4):443-447. doi:10.1002/ajh.23623.
John V. Mitsios. Distinguishing In Vivo Versus In Vitro Hemolysis. CLN Ask the Expert: December 2018. Available online at https://www.aacc.org/publications/cln/articles/2018/december/distinguishing-in-vivo-versus-in-vitro-hemolysis. Accessed on 8/26/2020.
Contemporary Practice in Clinical Chemistry. William Clarke and Mark Marzinke. 4th Edition, AACC Press, Elsevier.
RE Langlois M, Delanghe J. Clin Chem 1996;42:1589-1600.
Sources Used in Previous Reviews
Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO. Pp 466-467.
(© 2005). Haptoglobin. ARUP's Guide to Clinical Laboratory Testing [On-line information]. Available online at http://www.aruplab.com/guides/clt/tests/clt_291a.jsp#4273706.
Dhaliwal, G. et. al. (2004 June 1). Hemolytic Anemia. American Family Physician [On-line journal]. Available online at http://www.aafp.org/afp/20040601/2599.html.
Nanda, R., Updated (2005 February 1). Haptoglobin. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003634.htm.
(© 1995-2005). Autoimmune Hemolytic Anemia. Merck Manual-Second Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/sec14/ch172/ch172f.html?qt=haptoglobin&alt=sh.
O-Hara Paggen, M. (1999 September 1). HELLP Syndrome: Recognition and Perinatal Management. American Family Physician [On-line journal]. Available online at http://www.aafp.org/afp/990901ap/829.html.
Sibai, B. (2004 May). Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count. ACOG, High-Risk Pregnancy Series: An Expert's View v 103 (5 part 1). [On-line journal]. Available online at http://www.mccn.edu/library/ABOG/2005/PMID15121574.pdf#search='test%20haptoglobin'.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Pp 199.
Wu, A. (2006). Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders Elsevier, St. Louis, Missouri. Pp 512-513.
Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition]. Pp 840.
Levin, M. (2007 March 8). Haptoglobin. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003634.htm . Accessed on 11/23/08.
(2006 September). What is Hemolytic Anemia? National Heart Lung and Blood Institute [On-line information]. Available online at http://www.nhlbi.nih.gov/health/dci/Diseases/ha/ha_whatis.html. Accessed on 11/23/08.
Schick, P. (2007 January 29). Hemolytic Anemia. eMedicine [On-line information]. Available online at http://www.emedicine.com/med/TOPIC979.HTM. Accessed on 11/23/08.
Gersten, T. (Updated 2012 February 8). Haptoglobin. MedlinePlus Medical Encyclopedia. [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003634.htm. Accessed August 2012.
(© 1995–2012). Haptoglobin, Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/9168. Accessed August 2012.
Lichtin, A. (Revised 2009 February). Overview of Hemolytic Anemia. Merck Manual for Healthcare Professionals [On-line information]. Available online through http://www.merck.com. Accessed August 2012.
(2011 April 1). What is Hemolytic Anemia? National Heart Lung and Blood Institute [On-line information]. Available online at http://www.nhlbi.nih.gov/health/health-topics/topics/ha/. Accessed August 2012.
Schick, P. (Updated 2011 August 8). Hemolytic Anemia. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/201066-overview. Accessed August 2012.
(2008 November). Haptoglobin (HP) Genotyping. ARUP Laboratories Technical Bulletin [On-line information]. Available online through https://www.aruplab.com. Accessed August 2012.
Cook, J. et. al. (Updated 2011 July). Hemolytic Anemias. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/HemolyticAnemias.html?client_ID=LTD#tabs=0. Accessed August 2012.
2016 review performed by Shawn Clinton, Ph.D., DABCC, Laboratory Director and the Lab Tests Online Editorial Review Board.
(February 2, 2014) Gersten T. Hemolytic anemia. MedlinePlus Medical Encyclopedia. Available online at https://www.nlm.nih.gov/medlineplus/ency/article/000571.htm. Accessed May 2016.
(Updated: March 21, 2014) NIH National Heart Lung and Blood Institute. What is Hemolytic Anemia? Available online at https://www.nhlbi.nih.gov/health/health-topics/topics/ha/diagnosis. Accessed May 2016.
Henry's Clinical Diagnosis and Management by Laboratory Methods, 21st Edition, Pg. 237, by Richard A. McPherson MD MSc (Author), Matthew R. Pincus MD PhD (Author).
Kristiansen M1, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature. 2001 Jan 11;409(6817):198-201.
Wintrobe's Clinical Hematology. 12th ed. Greer J, Foerster J, Rodgers G, Paraskevas F, Glader B, Arber D, Means R, eds. Philadelphia, PA: Lippincott Williams & Wilkins: 2009, Pg 800.
Harmening D. Clinical Hematology and Fundamentals of Hemostasis, Fifth Edition, F.A. Davis Company, Philadelphia, 2009, Pg 177.
(November 15, 2015) Schick P. Hemolytic Anemia Workup. Medscape Reference. Available online at http://emedicine.medscape.com/article/201066-workup. Accessed May 2016.